Genovis AB Ownership
| GENO Stock | SEK 26.25 0.20 0.76% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Genovis |
Genovis Stock Ownership Analysis
About 24.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 976.19. Genovis AB had not issued any dividends in recent years. The entity had 1:10 split on the 4th of April 2012. Genovis AB develops, produces, and sells tools for developing new medications and diagnostics for customers in the medical device and pharmaceutical industries. Genovis AB was founded in 1999 and is based in Lund, Sweden. Genovis AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 20 people. To learn more about Genovis AB call Fredrik Olsson at 46 46 10 12 30 or check out https://www.genovis.com.Genovis AB Outstanding Bonds
Genovis AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genovis AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genovis bonds can be classified according to their maturity, which is the date when Genovis AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genovis Stock Analysis
When running Genovis AB's price analysis, check to measure Genovis AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovis AB is operating at the current time. Most of Genovis AB's value examination focuses on studying past and present price action to predict the probability of Genovis AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovis AB's price. Additionally, you may evaluate how the addition of Genovis AB to your portfolios can decrease your overall portfolio volatility.